Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.11M Sell
6,000
-7,500
-56% -$2.67M 0.56% 41
2025
Q4
$4.42M Buy
13,500
+2,000
+17% +$634K 1.19% 25
2025
Q3
$3.25M Buy
11,500
+1,000
+10% +$290K 1.04% 30
2025
Q2
$2.93M Buy
10,500
+3,675
+54% +$1.04M 1.36% 29
2025
Q1
$2.13M Buy
6,825
+1,000
+17% +$295K 1.02% 36
2024
Q4
$1.52M Sell
5,825
-5,175
-47% -$1.54M 0.73% 42
2024
Q3
$3.54M Buy
11,000
+2,500
+29% +$818K 1.42% 20
2024
Q2
$2.66M Sell
8,500
-1,800
-17% -$529K 1.37% 20
2024
Q1
$2.93M Buy
10,300
+3,300
+47% +$966K 1.44% 19
2023
Q4
$2.02M Sell
7,000
-1,400
-17% -$381K 1.09% 27
2023
Q3
$2.26M Sell
8,400
-8,475
-50% -$2.12M 1.23% 21
2023
Q2
$3.75M Buy
16,875
+6,875
+69% +$1.6M 1.98% 14
2023
Q1
$2.42M Buy
+10,000
New +$2.45M 1.48% 21
2022
Q1
Sell
-12,750
Closed -$2.87M 69
2021
Q4
$2.87M Buy
12,750
+1,500
+13% +$317K 1.16% 25
2021
Q3
$2.39M Hold
11,250
1.06% 28
2021
Q2
$2.74M Hold
11,250
0.97% 27
2021
Q1
$2.8M Hold
11,250
1.22% 25
2020
Q4
$2.59M Hold
11,250
1.07% 28
2020
Q3
$2.86M Sell
11,250
-500
-4% -$124K 1.46% 24
2020
Q2
$2.77M Sell
11,750
-1,500
-11% -$342K 1.55% 21
2020
Q1
$2.69M Buy
13,250
+750
+6% +$164K 1.76% 19
2019
Q4
$3.01M Buy
+12,500
New +$2.76M 1.91% 20

Other funds holding AMGN

DCF Advisers's AMGN Position: Q1 2026 in Review

DCF Advisers reduced its Amgen (AMGN) stake by 56% in Q1 2026, selling an estimated $2.67M and leaving 6,000 shares worth $2.11M. The position accounts for 0.56% of the portfolio, ranked #41.

DCF Advisers first reported a position in AMGN in Q4 2019 and has held it in 22 quarters since. The position peaked at $4.42M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • DCF Advisers held 6,000 shares of Amgen worth $2.11M as of Q1 2026.
  • DCF Advisers sold 7,500 Amgen shares in Q1 2026, an estimated $2.67M.
  • Amgen made up 0.56% of DCF Advisers's portfolio in Q1 2026, its #41 holding.
  • DCF Advisers first reported a position in Amgen in Q4 2019 and has held it in 22 quarters since.
  • DCF Advisers's Amgen position peaked at $4.42M in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.